01—Abstract
Summary
Summary of the 8-K filed September 30, 2025. Cited figures are marked; the original filing is the authoritative source.
CRH plc used its September 30, 2025 Investor Day to set out its strategy and financial targets for 2026-2030, furnishing a press release (Exhibit 99.1) and five presentation decks under Item 7.01 rather than filing them as formal financial statements.
The headline targets are average annual revenue growth of 7% to 9% on a total basis (organic plus inorganic), an Adjusted EBITDA margin of 22% to 24% by 2030, and average annual Adjusted Free Cash Flow Conversion above 100%. The company also reaffirmed its 2025 guidance of Adjusted EBITDA of $7.5 billion to $7.7 billiona and net income of $3.8 billion to $3.9 billion, noting that this guidance excludes any impact from the recently acquired Eco Material Technologies. Management framed the next five years around roughly $40 billion of projected financial capacity, about 70% of which is earmarked for growth investments (organic capex and M&A) and about 30% for shareholder returns.
This compares with roughly $27 billionb deployed over 2020-2024, split about 55% growth and 45% shareholder returns. The company also highlighted an approximately $8 billion growth capex pipeline for 2024-2028, of which about 30% had been spent as of June 30, 2025, and described a deliberate near-term step-up in growth capex. The capital allocation plan is explicitly described as indicative and dependent on future value-creation opportunities.
For investors, the filing is primarily a guidance and strategy update rather than a reported-results event. The most decision-relevant items are the margin expansion target (from 19.5%c in 2024 to 22% to 24%), the reliance on non-GAAP metrics such as Adjusted EBITDA, Adjusted FCF Conversion, and Adjusted ROIC, and the fact that the financial capacity and growth-investment figures are forward-looking and subject to the risks in CRH's 2024 Form 10-K. The filing does not provide a quantitative reconciliation for the 2030 margin and FCF conversion targets, citing unreasonable effort.
02—Key points
Key Highlights
- 2026-2030 targets: average annual revenue growth of 7% to 9% (total, including M&A), Adjusted EBITDA margin of 22% to 24% by 2030, and average annual Adjusted FCF conversion above 100%.
- 2025 guidance reaffirmed: Adjusted EBITDA of $7.5B to $7.7B and net income of $3.8B to $3.9B, excluding any impact from the Eco Material Technologies acquisition.
- Capital deployment outlook: approximately $40B of financial capacity over 2026-2030, with roughly 70% targeted for growth (organic capex and M&A) and 30% for shareholder returns, versus about $27B deployed over 2020-2024 (roughly 55% growth / 45% returns).
- Growth capex step-up: an approximately $8B growth capex pipeline for 2024-2028, about 30% spent as of June 30, 2025, with CRH noting it uses a recently revised internal definition of growth capex.
- Cementitious expansion: the Eco Material acquisition (closed September 15, 2025) is described as increasing US cementitious capacity by about 60% to roughly 25 million tonnes annually, a potential driver of future growth and margin.
- Scale and track record: 2024 revenues of $35.6B, Adjusted EBITDA of $6.9B (19.5% margin, up 920bps since 2014), Adjusted FCF of $4.2B, and Adjusted ROIC of 13.4%, with management citing 11 consecutive years of margin expansion.
- Filing is furnished, not filed: the Item 7.01 information is excluded from Section 18 liability, and the company notes the 8-K is not an admission of materiality, which limits its legal weight relative to a filed disclosure.
03—Questions
Frequently Asked Questions
What are CRH's new five-year financial targets, and how do they compare with recent performance?
CRH targets average annual revenue growth of 7% to 9% from 2026 to 2030 on a total basis, including both organic and acquisition-driven growth. It targets an Adjusted EBITDA margin of 22% to 24% by 2030, compared with 19.5% in 2024, implying meaningful margin expansion. It also targets average annual Adjusted FCF conversion above 100%. Over 2014-2024, the company cited revenue CAGR of about 8% and Adjusted EBITDA CAGR of about 15%, so the revenue target is roughly in line with its historical pace while the margin target assumes continued expansion.
Did CRH change its 2025 guidance?
No. CRH reaffirmed its 2025 guidance, including Adjusted EBITDA of $7.5B to $7.7B and net income of $3.8B to $3.9B, as published on August 6, 2025. The company noted that this guidance does not reflect any financial impact from the Eco Material Technologies acquisition, which closed on September 15, 2025, so the reported 2025 figures may differ once that contribution is included.
How will CRH allocate capital over 2026-2030?
Management estimates roughly $40 billion of financial capacity (cash and debt financing available after maintenance capex) over the period, with about 70% directed to growth investments (organic capex and M&A) and about 30% to shareholder returns. Management stresses that these figures are indicative only and that actual deployment depends on value-creation opportunities. The company's stated approach is to prioritize value-accretive growth in fragmented markets, including aggregates, cementitious, roads and water.
Why does the filing matter for investors, and what are its limitations?
The filing is a strategy and guidance update rather than a set of audited results. Most of the new figures, including the 2030 targets and capital deployment estimates, are forward-looking and subject to risks such as interest rates, construction demand, public funding, and acquisition execution. Several key metrics (Adjusted EBITDA margin and Adjusted FCF conversion for future periods) are non-GAAP, and CRH states it cannot provide quantitative GAAP reconciliations for them without unreasonable effort. The exhibits are furnished under Item 7.01, so they are not treated as filed for Section 18 liability purposes.
04—Continue